Sky Century Investment (SKYI) Amortizatization of Intangibles (2024 - 2026)
Sky Century Investment's (SKYI) quarterly Amortizatization of Intangibles came in at $12227.0 in Q2 2026, down 1.58% year-on-year from $12423.0 in Q2 2025, and up 4.86% on a QoQ basis from $11660.0 in Q1 2026.
Sky Century Investment (SKYI) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 3 years of Amortizatization of Intangibles data on file, last reported at $12227.0 in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 1.58% year-over-year to $12227.0 in Q2 2026; TTM through May 2026 was $59356.0, a 33.98% increase from a year earlier, with the FY2025 full-year figure at $51859.0, up 49.57% from the prior year.
- Amortizatization of Intangibles for Q2 2026 stood at $12227.0, up from $11660.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for SKYI reached as high as $18459.0 in Q4 2025 and fell as low as $8407.0 in Q2 2024.
- Historically, Amortizatization of Intangibles has averaged $12451.7 across 3 years, with a median of $11660.0 in 2026.
- Across the five-year window, Amortizatization of Intangibles jumped 79.94% in 2025 and decreased 1.58% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $10781.0 in 2024, then jumped by 71.22% to $18459.0 in 2025, then slumped by 33.76% to $12227.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $12227.0 in Q2 2026, $11660.0 in Q1 2026, and $18459.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Sky Century Investment | 944,514.46 | 944,250.46 | 26,045.00 | 12,227.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 12,227.00 |
| May 31, 2026 | 12,227.00 |
| Feb 28, 2026 | 11,660.00 |
| Feb 28, 2026 | 11,660.00 |
| Nov 30, 2025 | 18,459.00 |
| Nov 30, 2025 | 18,459.00 |
| Aug 31, 2025 | 17,010.00 |
| Aug 31, 2025 | 17,010.00 |
| May 31, 2025 | 12,423.00 |
| May 31, 2025 | 12,423.00 |
| Feb 28, 2025 | 11,645.00 |
| Feb 28, 2025 | 11,645.00 |
| Nov 30, 2024 | 10,781.00 |
| Nov 30, 2024 | 10,781.00 |
| Aug 31, 2024 | 9,453.00 |
| Aug 31, 2024 | 9,453.00 |
| May 31, 2024 | 8,407.00 |
| May 31, 2024 | 8,407.00 |